Down 70% since 2021 due to legal issues involving their Philips Respironics units, Philips has now set aside $575M for the medical device litigation costs – costs much lower than many anticipated. The company reported an almost 50% jump in first-quarter core profit to 359 million euros, with sales up 6% from a year earlier.
Philips is a household brand that sells TVs, monitors, shavers, lighting equipment, respiratory devices amongst a number of other electronic products.
What are your thoughts on this stock moving forward? Can it go back to its levels prior to the legal issues?
Leave a Reply